A detailed history of Ameritas Advisory Services, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Ameritas Advisory Services, LLC holds 73,350 shares of PFE stock, worth $2.01 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
73,350
Previous 80,373 8.74%
Holding current value
$2.01 Million
Previous $2.25 Million 5.6%
% of portfolio
0.09%
Previous 0.09%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$27.7 - $31.39 $194,537 - $220,451
-7,023 Reduced 8.74%
73,350 $2.12 Million
Q2 2024

Jul 29, 2024

SELL
$25.26 - $29.6 $79,821 - $93,536
-3,160 Reduced 3.78%
80,373 $2.25 Million
Q1 2024

May 14, 2024

BUY
$25.89 - $29.73 $881,916 - $1.01 Million
34,064 Added 68.86%
83,533 $2.32 Million
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $1.38 Million - $1.8 Million
-53,002 Reduced 51.72%
49,469 $1.42 Million
Q3 2023

Nov 13, 2023

BUY
$32.09 - $37.51 $2.14 Million - $2.51 Million
66,796 Added 187.23%
102,471 $3.4 Million
Q2 2023

Jul 25, 2023

SELL
$36.12 - $41.79 $2.69 Million - $3.11 Million
-74,406 Reduced 67.59%
35,675 $1.31 Million
Q1 2023

Apr 28, 2023

SELL
$39.39 - $51.28 $738,956 - $962,012
-18,760 Reduced 14.56%
110,081 $4.49 Million
Q4 2022

Feb 10, 2023

BUY
$41.75 - $54.5 $342,642 - $447,281
8,207 Added 6.8%
128,841 $6.6 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $81,787 - $99,841
-1,869 Reduced 1.53%
120,634 $5.28 Million
Q2 2022

Aug 10, 2022

BUY
$46.53 - $55.17 $193,146 - $229,010
4,151 Added 3.51%
122,503 $6.42 Million
Q1 2022

May 04, 2022

BUY
$45.75 - $56.69 $226,874 - $281,125
4,959 Added 4.37%
118,352 $6.13 Million
Q4 2021

Feb 07, 2022

BUY
$41.32 - $61.25 $4.69 Million - $6.95 Million
113,393 New
113,393 $6.7 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Ameritas Advisory Services, LLC Portfolio

Follow Ameritas Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Advisory Services, LLC with notifications on news.